Market Report, "Ukraine Pharmaceuticals & Healthcare Report Q2 2013", Published
Ukraine's legislative environment is continuing to hamper access to market for foreign drugmakers and cause tensions between authorities and the industry. Despite being postponed by three months, to the start of March 2013, the import licensing law No 5038-VI will undoubtedly create severe drug shortages and the withdrawal of drug companies from Ukraine, as it stipulates that all pharmaceutical importers must obtain a special new licence. Given factors such as the lack of resources to implement the issuing of new...
View full press release